Artificial intelligence (AI) is rapidly reshaping global health, from disease surveillance to drug and diagnostic discovery and development to the delivery of information, products and services—bringing both new opportunities and new risks. In the HIV response, AI is being applied across prevention, treatment and care, offering the potential to expand reach, strengthen efforts, and improve the response, but also creating various risks, which makes responsible, community-focused practice an imperative.
AVAC is following this evolving landscape and working with partners to understand what AI means for HIV prevention, research and the broader response. See below for AVAC’s quarterly AI + HIV newsletter and important resources.
Stay up-to-date!
Sign up to receive AVAC’s quarterly AI + HIV newsletter at avac.org/signup.
AI + HIV Newsletter
Guided by a distinguished editorial advisory group, this quarterly resource provides advocates and the global community with the information and resources to engage with AI in ways that strengthen equity, protect individuals and communities and prioritize their inclusion, and ensure that technological innovation advances the HIV response rather than undermines it.
- Issue 1, May 2026
Editorial Board
AVAC’s quarterly AI + HIV newsletter is supported by small advisory group with deep expertise in both HIV and artificial intelligence, representing diverse global, regional and advocacy perspectives.
- Solange Baptiste, ITPC Global
- Cheryl Johnson, WHO
- Shawn Malone, PSI
- Ntombifikile Mtshali, Shout-it-Now
- Sarah Morris, Audere
- Simon Odiwuor K’Ondiek, Nyanza Reproductive Health Society
- Jirair Ratevosian, Duke University
- mike Reid, UCSF